Ackermann R - Search Results

1

p21 and p53 Immunostaining and survival following systemic chemotherapy for urothelial cancer.

Jankevicius F, Goebell P, Kushima M, Schulz WA, Ackermann R, Schmitz-Dräger BJ. Jankevicius F, et al. Among authors: ackermann r. Urol Int. 2002;69(3):174-80. doi: 10.1159/000063949. Urol Int. 2002. PMID: 12372883

2

P53 accumulation in precursor lesions and early stages of bladder cancer.

Schmitz-Dräger BJ, van Roeyen CR, Grimm MO, Gerharz CD, Decken K, Schulz WA, Bültel H, Makri D, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: ackermann r. World J Urol. 1994;12(2):79-83. doi: 10.1007/BF00184241. World J Urol. 1994. PMID: 8087143

3

Dual-parameter immunoflow cytometry--a new technique in the noninvasive diagnosis of bladder cancer.

Jankevicius F, Shibayama T, Decken K, Bojar H, Ebert T, Ackermann R, Schmitz-Dräger BJ. Jankevicius F, et al. Among authors: ackermann r. Urol Int. 1995;55(2):68-73. doi: 10.1159/000282754. Urol Int. 1995. PMID: 8533198

4

p53 and MDM2 in the development and progression of bladder cancer.

Schmitz-Dräger BJ, Kushima M, Goebell P, Jax TW, Gerharz CD, Bültel H, Schulz WA, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: ackermann r. Eur Urol. 1997;32(4):487-93. Eur Urol. 1997. PMID: 9412812

5

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines.

Cronauer MV, Schulz WA, Burchardt T, Ackermann R, Burchardt M. Cronauer MV, et al. Among authors: ackermann r. Oncogene. 2004 Apr 29;23(20):3541-9. doi: 10.1038/sj.onc.1207346. Oncogene. 2004. PMID: 15077179

6

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.

Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO. Kramer C, et al. Among authors: ackermann r. Cancer. 2007 May 15;109(10):2016-24. doi: 10.1002/cncr.22627. Cancer. 2007. PMID: 17394193 Free article.

7

A new and reliable culture system for superficial low-grade urothelial carcinoma of the bladder.

Seifert HH, Meyer A, Cronauer MV, Hatina J, Müller M, Rieder H, Hoffmann MJ, Ackermann R, Schulz WA. Seifert HH, et al. Among authors: ackermann r. World J Urol. 2007 Jun;25(3):297-302. doi: 10.1007/s00345-007-0166-7. Epub 2007 Apr 18. World J Urol. 2007. PMID: 17440731 Free article.

8

[A study of the quantitative dual-parameter flow cytometry analyses of cellular antigens on transitional cells for the diagnosis of bladder cancer].

Shibayama T, Decken K, Severin M, Ebert T, Ackermann R, Schmitz-Dräger BJ, Bojar H. Shibayama T, et al. Among authors: ackermann r. Nihon Hinyokika Gakkai Zasshi. 1993 Aug;84(8):1432-40. doi: 10.5980/jpnjurol1989.84.1432. Nihon Hinyokika Gakkai Zasshi. 1993. PMID: 8411804 Free article. Japanese.

9

Molecular biology of dissemination in bladder cancer--laboratory findings and clinical significance.

Schmitz-Dräger BJ, Jankevicius F, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: ackermann r. World J Urol. 1996;14(3):190-6. doi: 10.1007/BF00186899. World J Urol. 1996. PMID: 8806198 Review.

10

c-myc in bladder cancer. Clinical findings and analysis of mechanism.

Schmitz-Dräger BJ, Schulz WA, Jürgens B, Gerharz CD, van Roeyen CR, Bültel H, Ebert T, Ackermann R. Schmitz-Dräger BJ, et al. Among authors: ackermann r. Urol Res. 1997;25 Suppl 1:S45-9. doi: 10.1007/BF00942047. Urol Res. 1997. PMID: 9079756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

677 results

Search Page

Filters